Peanut and egg study for expecting mothers
Part of Immune system & allergy clinical trials.
This study looks at whether eating or avoiding peanuts and eggs during pregnancy can affect the baby's risk of allergies. You and your baby will be followed for a year after birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and pregnant (up to 27 weeks).
- You or your baby's father or a full sibling has a diagnosed allergy condition like asthma, hay fever, eczema, or food allergy.
- You have eaten peanuts and eggs without having an allergic reaction.
- You plan to breastfeed for more than 3 months.
- Your pregnancy has been healthy with no diabetes, high blood pressure, or severe morning sickness.
- You are willing to be assigned by chance to either eat or avoid peanuts and eggs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether special skin care routines in the first year of life can help prevent allergies and skin problems in babies who are at higher risk. It might be a good fit if your baby is a healthy full-term newborn and has at least one risk factor, like being an only child or having a family history of allergies or asthma.
This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.
This study looks at how quickly children with possible egg and/or milk allergy are correctly diagnosed, and how follow-up checks affect their nutrition and growth. It may help you understand whether timely diagnosis and good monitoring could reduce problems with eating, weight, or growth.
This trial tests an oral (by mouth) immune-based treatment to reduce egg allergy reactions in children ages 6 to 16. It may help some kids become more tolerant to egg, but it requires careful screening and follow-through.
This study checks on children and young people 5 to 15 years after they finished an 18-month oral immunotherapy treatment for peanut, egg, or milk allergy. It helps researchers understand how their allergies and health are doing over the long term.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
Hear when a new Allergy and Immunology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.